AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comSEP 32 min read$CLX

Can Cost Savings Offset Inflation & Protect Clorox's Margins?

Clorox (CLX) reported a 520 basis point gross margin contraction in Q4 fiscal 2026 due to inflation and mix challenges. The company is focusing on cost savings and productivity initiatives to offset inflationary pressures, but expects margins to remain pressured in fiscal 2027. CLX shares have risen 5.2% in the past three months, with a forward P/E of 15.97X.

Original reporting
finance.yahoo.com
Published Sep 3, 2026, 2:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 4:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Can Cost Savings Offset Inflation & Protect Clorox's Margins? — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CLXBearishMed
01

Why it matters

The margin decline and modest FY2027 guidance may weigh on the stock, but cost‑saving initiatives could mitigate downside if executed effectively.

02

Market read

The guidance update provides fresh data for traders evaluating CLX and its peers in the consumer‑staples sector.

03

What to watch

Potential pricing power from brand strength and upcoming product innovations are not addressed.

Relevance 7/10Novelty 6/10Timing: post‑earnings guidance release

Background

Clorox reported Q4 FY2026 results with a gross margin decline and outlined cost‑saving programs after completing an ERP transition.

Company-level read

Ticker impact

$CLXBearishMedium confidence
Context

Clorox disclosed Q4 FY2026 gross margin fell 520 bps YoY to 41.3% and projected FY2027 gross margin of 42% amid inflation pressures.

Expected impact

Potential short‑term downside pressure on CLX price.

Evidence & confidence

Guidance below prior expectations and a large margin decline indicate earnings risk.

Market effects

Sector

Consumer staples margins may be pressured by inflation, affecting peers.

Regional

U.S. consumer‑staples investors may reassess cost‑inflation outlook.

Global

Limited to U.S. market; no broader macro impact.

Counterpoint

What could challenge this read

If Clorox can accelerate cost‑saving initiatives, margins could rebound faster than guidance suggests.

Key entities

  • Company
    Clorox Company

    Consumer‑staples manufacturer (ticker CLX).

Read at source← All news

Related articles

SEP 17
$CLXMedAI 8/10

Clorox stock hits 52-week low at 84.69 USD

Clorox (CLX) stock hit a 52-week low of $84.74, down 31.51% over the past year. Despite this, InvestingPro suggests it's undervalued with a 5.89% dividend yield. Q4 earnings per share were $1.66, missing estimates. UBS raised its price target to $105, maintaining a Neutral rating. Goldman Sachs and Morgan Stanley reported on broader consumer staples trends.

investing.com2 min
AUG 21
$CLXMedAI 8/10

How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook

Clorox (CLX) expects fiscal 2027 net sales to rise 13-14%, with GOJO contributing 9.5 points. Q1 sales projected at 31-32%, including 15 points from GOJO. Adjusted earnings forecasted at $5.70-$6.00 per share, up 3-8%. Gross margin expected at 42%, with pressure from GOJO inventory costs and inflation. Integration costs and inflation pose near-term challenges.

tradingview.com3 min
AUG 21
$CLXMedAI 8/10

Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure?

Clorox (CLX) reports Q4 net sales of $1.95B, up 2% YoY, with GOJO contributing 10 percentage points. Fiscal 2027 sales expected to rise 13-14%, with adjusted EPS at $5.70-$6.00. Gross margins declined due to inflation and higher costs. Organic sales growth is muted, with ERP comparisons aiding growth. CLX trades at 17.9X forward earnings, below its sub-industry multiple.

tradingview.com3 min
AUG 14
$CLXMed

Are Wall Street Analysts Predicting Clorox Stock Will Climb or Sink?

The article says The Clorox Company (CLX) shares have lagged the S&P 500 over 52 weeks, down 13.7% versus SPX up 20.6%. After Q4 2026 results on Aug. 3, CLX rose 6.5% on $1.95B sales and adjusted EPS $1.66, plus FY2027 net sales growth guidance of 13%-14%. Analysts: consensus Hold, JPMorgan raised PT to $95; stock trades above the mean $96.94, with a Street-high $117.

yahoo.com6 min
AUG 11
$CLXMedAI 8/10

Clorox (CLX) Q4 2026 Earnings Call Transcript

Clorox (CLX) reported Q4 FY2026 net sales of $1.95B, down 2% (GOJO added about 10 points). Organic sales fell 13% and adjusted EPS was $1.66, down 42%. Gross margin was 41.3%. For FY2027, it guided organic sales growth of 3.5% to 4.5% and adjusted EPS of $5.70 to $6.00, citing inflation headwinds of $200M+.

fool.com6 min
AUG 6
$CLXMed

The Clorox Company Q4 2026 Earnings Call Summary

Clorox held its Q4 2026 earnings call, citing value-seeking consumer behavior and inflation pressures. Management said most categories have recovered from a prior cyberattack, with Litter still lagging. It highlighted GOJO acquisition synergies, fiscal 2027 assumptions including Brent at $90/bbl, inflation over $200M, and free cash flow of 11% to 13% of sales.

yahoo.com7 min